How COVID-19 could benefit tuberculosis and HIV services in South Africa

Lancet Respir Med. 2020 Sep;8(9):844-846. doi: 10.1016/S2213-2600(20)30311-8. Epub 2020 Aug 3.

Authors

Claire Keene¹, Erika Mohr-Holland¹, Tali Cassidy¹, Vera Scott², Aurelie Nelson³, Jennifer Furin⁴, Laura Triviño-Duran³

Affiliations

¹ Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
² School of Public Health, University of Cape Town, Cape Town, South Africa.
³ Médecins Sans Frontières, South African Mission, Cape Town, South Africa.
⁴ Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: jenniferfurin@gmail.com.

No abstract available

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections / microbiology
Coronavirus Infections / prevention & control*
Coronavirus Infections / transmission
Counseling / methods
Delivery of Health Care / methods*
Disease Transmission, Infectious / prevention & control*
HIV Infections / therapy*
HIV Infections / transmission
Humans
Pandemics / prevention & control*
Pneumonia, Viral / microbiology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / transmission
SARS-CoV-2
South Africa
Telemedicine / methods
Tuberculosis / therapy*
Tuberculosis / transmission